Ramadan fasting and blood pressure treatment in adrenal insufficiency
Part of Heart & circulation clinical trials.
This study looks at how fasting during Ramadan affects people with secondary adrenal insufficiency (a condition where the body doesn't produce enough cortisol). It compares your blood pressure symptoms before and after a treatment for low blood pressure, to see if the treatment helps you fast safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with secondary adrenal insufficiency (your body doesn't make enough of a certain hormone).
- You have been taking steroids (glucocorticoids) as replacement therapy for more than one year.
- You took part in the hospital's previous study on this topic in 2023.
- You plan to fast during Ramadan in 2025.
- You do not have other serious health issues like heart, kidney, liver, or lung disease, diabetes, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether it is safe for people with primary adrenal insufficiency to fast during Ramadan, and checks for any risks. It is for those who are already on stable replacement treatment and want to fast in 2026.
This trial measures hormone levels in blood during a procedure to treat high blood pressure caused by an adrenal gland problem. It may help doctors understand how the body responds during treatment.
This study looks at how people with type 2 diabetes experience fasting during Ramadan. By joining, you'll help researchers understand the challenges and benefits of fasting with diabetes.
This study tests a minimally invasive procedure called superselective adrenal arterial embolization for people whose high blood pressure is hard to control with medications. The goal is to see if this treatment can safely lower blood pressure.
This trial tests a new medication, clofutriben, for people with hard-to-control type 2 diabetes who might also have mild excess of a stress hormone called cortisol. It aims to see if the drug can help lower blood sugar and improve diabetes management.
This Phase 3 trial tests whether giving hydrocortisone plus fludrocortisone to critically ill ICU patients with suspected “corticosteroid insufficiency” can improve outcomes without relying on steroids already being used. It may help patients whose bodies aren’t making enough stress hormones during severe illness.
Hear when a new Hypotension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.